লাত্ভিয়া -
লাত্ভীয় -
Zāļu valsts aģentūra
otrivin total 0,5 mg/ml + 0,6 mg/ml deguna aerosols, šķīdums
glaxosmithkline dungarvan ltd., ireland - xylometazolini hydrochloridum, ipratropii bromidum - deguna aerosols, šķīdums - 0,5 mg/ml + 0,6 mg/ml
ইউরোপীয় ইউনিয়ন -
লাত্ভীয় -
EMA (European Medicines Agency)
alunbrig
takeda pharma a/s - brigatinib - karcinoma, nesīkšūnu plaušas - antineoplastiski līdzekļi - alunbrig is indicated as monotherapy for the treatment of adult patients with anaplastic lymphoma kinase (alk)‑positive advanced non‑small cell lung cancer (nsclc) previously not treated with an alk inhibitor. alunbrig is indicated as monotherapy for the treatment of adult patients with anaplastic lymphoma kinase alkpositive advanced nsclc previously treated with crizotinib.
লাত্ভিয়া -
লাত্ভীয় -
Pārtikas un veterinārais dienests, Zemkopības ministrija
sambucus gummies (paziņots 2015.) cits, košļājamā pastila
nature’s way products, inc. - cits, košļājamā pastila
লাত্ভিয়া -
লাত্ভীয় -
Pārtikas un veterinārais dienests, Zemkopības ministrija
loprofin low protein mix cits, milti
sia ''oriola rĪga'' 50003199991 rīga, dzelzavas iela 120m, rīga, lv-1021 - cits, milti - cits - paredzēts lietošanai cilvēkiem ar veselības traucējumiem, kuriem ir nepieciešama diēta ar samazinātu olbaltumvielu daudzumu – iedzimtu vielmaiņas slimību, nieru mazspējas un aknu mazspējas gadījumā
ইউরোপীয় ইউনিয়ন -
লাত্ভীয় -
EMA (European Medicines Agency)
mhyosphere pcv id
laboratorios hipra, s.a. - mycoplasma hyopneumoniae, strain 7304 (nexhyon), expressing the capsid protein of porcine circovirus type 2a, inactivated - immunologicals for suidae, inactivated viral and inactivated bacterial vaccines - cūkas - for the active immunisation of pigs:to reduce lung lesions associated with porcine enzootic pneumonia caused by mycoplasma hyopneumoniae. also, to reduce the incidence of these lesions (as observed in field studies). to reduce viraemia, virus load in lungs and lymphoid tissues and the duration of the viraemic period associated with diseases caused by porcine circovirus type 2 (pcv2). efficacy against pcv2 genotypes a, b and d has been demonstrated in field studies. to reduce culling rate and the loss of daily weight gain caused by mycoplasma hyopneumoniae and/or pcv2 related diseases (as observed at 6 months of age in field studies). mycoplasma hyopneumoniae: onset of immunity: 3 weeks after vaccinationduration of immunity: 23 weeks after vaccinationporcine circovirus type 2:onset of immunity: 2 weeks after vaccinationduration of immunity: 22 weeks after vaccinationin addition, a reduction in nasal and faecal shedding and the duration of nasal excretion of pcv2 was demonstrated in animals challenged at 4 weeks and at 22 weeks after vaccination.
ইউরোপীয় ইউনিয়ন -
লাত্ভীয় -
EMA (European Medicines Agency)
koselugo
astrazeneca ab - selumetinib sulfate - neurofibromatosis 1 - antineoplastiski līdzekļi - koselugo as monotherapy is indicated for the treatment of symptomatic, inoperable plexiform neurofibromas (pn) in paediatric patients with neurofibromatosis type 1 (nf1) aged 3 years and above.
লাত্ভিয়া -
লাত্ভীয় -
Zāļu valsts aģentūra
opexa 6 mg/ml acu pilieni, šķīdums
menarini international operations luxembourg s.a., luxembourg - bilastīns - acu pilieni, šķīdums - 6 mg/ml
লাত্ভিয়া -
লাত্ভীয় -
Zāļu valsts aģentūra
enoxaparin ledraxen 2000 sv (20 mg)/0,2 ml šķīdums injekcijām pilnšļircē
venipharm sas, france - enoksaparīna nātrija sāls - Šķīdums injekcijām pilnšļircē - 2000 sv (20 mg)/0,2 ml
লাত্ভিয়া -
লাত্ভীয় -
Zāļu valsts aģentūra
enoxaparin ledraxen 4000 sv (40 mg)/0,4 ml šķīdums injekcijām pilnšļircē
venipharm sas, france - enoksaparīna nātrija sāls - Šķīdums injekcijām pilnšļircē - 4000 sv (40 mg)/0,4 ml
লাত্ভিয়া -
লাত্ভীয় -
Zāļu valsts aģentūra
enoxaparin ledraxen 6000 sv (60 mg)/0,6 ml šķīdums injekcijām pilnšļircē
venipharm sas, france - enoksaparīna nātrija sāls - Šķīdums injekcijām pilnšļircē - 6000 sv (60 mg)/0,6 ml